Categories
- Biomarkers
- Clinical Utility
- Clinical Validity
- Companion Diagnostics
- Digital Health
- Disruptive Innovation
- Drug Development
- Effectiveness
- Ethical, Legal, and Social Issues
- Event Calendar
- FDA
- Genomic Medicine
- High Throughput Next Generation Sequencing
- Medical Devices
- Molecular Diagnostics
- Our Consulting Services
- Partnering
- Personalized Medicine
- Rare Disorders
- Safety
- Therapeutics
Recent Posts
- Change in Process for FDA Medical Device Advisory Committees
- Myriad Breast Cancer Gene Patent Controversy: Upcoming Genetic Alliance Webinar
- New Hereditary Breast and Ovarian Cancer Gene: RAD51C
- Upcoming San Francisco Bay Area Biotech and Digital Health Events - April to June
- BayBio 2010 Conference Panel on Next Generation Sequencing - April 7, 2010
- Myriad Breast Cancer Gene Patents Invalidated
- Upcoming West Coast Biotech Events
- Looking for Funding? Opportunities to Pitch at BayBio 2010 Company Presentations Track
- Clinical Utility Consulting Operations Affected Today by Palo Alto Power Outage
- Clinical Utility Consulting: Doing Well on Google and Bing So Far
Our Favorite Places on the Web
- American College of Physicians
- American Society of Human Genetics
- Annals of Internal Medicine
- BioSpace
- Cancer and Your Genes
- DNA and You
- Eye on FDA
- FierceBiotech
- FierceMedicalDevices
- FiercePharma
- Genetic Future
- GenomeWeb
- Genomics Law Report
- Innoblog
- Innosight Institute Healthcare
- NCI
- New England Journal of Medicine
- NHGRI
- NIH
- TechCrunch
- VentureBeat
- WSJ Health Blog
- Xconomy
